DANCANN is a Danish manufacturer of cannabis for medical use. The company was founded in Marts 2018 and has been licensed for handling and cultivation of cannabis for medical use through the new pilot programme in Denmark.
DANCANN will create high quality cannabis at the best end to ensure the delivery of such a uniform, quality assured and standardized product as best possible by using high-tech indoor cultivation that in the future will be supplemented by green conversion - all this in close collaboration with The Danish Ministry of Health and the Danish Medicines Agency.
DANCANN will produce and sell raw materials as well as a number of processed cannabis products in the future. The target is directed towards the Scandinavian and European market that resembles our domestic market in line with the ongoing legalization of medical cannabis in the lead of an exponential market.
DANCANN's vision is to create world-class business results, including being among the best and biggest players in the market for medical cannabis while becoming Co2 neutral. This must be done through contributions with research-based products and highest quality services that improve disease control and exploitation of nature's resources.
DANCANN will support science and evidence of the good qualities cannabis contains - thereby making a significant contribution to research and development that improves human health and well-being.
DANCANN's dream is to prove that cannabis, the natural medicine, is recognized as a drug preparation, as well as make a difference to the many patients with good experiences with cannabis and its properties - thereby developing solutions for tomorrow's tough challenges - for the benefit of the individual and for the society.
Copyright © DANCANN 2018 All rights reserved